These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9674833)

  • 1. Acute encephalopathy associated with vigabatrin monotherapy in patients with mild renal failure.
    Ifergane G; Masalha R; Zigulinski R; Merkin L; Wirguin I; Herishanu YO
    Neurology; 1998 Jul; 51(1):314-5. PubMed ID: 9674833
    [No Abstract]   [Full Text] [Related]  

  • 2. Vigabatrin aggravates absences and absence status.
    Panayiotopoulos CP; Agathonikou A; Sharoqi IA; Parker AP
    Neurology; 1997 Nov; 49(5):1467. PubMed ID: 9371946
    [No Abstract]   [Full Text] [Related]  

  • 3. Vigabatrin and carbamazepine monotherapy for newly diagnosed epilepsy.
    Walker MC; Cockerell OC; Sander JW
    Arch Neurol; 1996 Jun; 53(6):477-8. PubMed ID: 8660147
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggravation of generalized epilepsies.
    Berkovic SF
    Epilepsia; 1998; 39 Suppl 3():S11-4. PubMed ID: 9593230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer antiepileptic drugs as monotherapy: data on vigabatrin.
    Fisher R; Kälviäinen R; Tanganelli P; Regesta G
    Neurology; 1996 Jul; 47(1 Suppl 1):S2-5. PubMed ID: 8677032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pancreatitis associated with dual vigabatrin and lamotrigine therapy.
    Jadresic D
    Seizure; 1994 Dec; 3(4):319. PubMed ID: 7534594
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute psychosis and vigabatrin in childhood].
    Chiaretti A; Castorina M; Tortorolo L; Piastra M; Polidori G
    Pediatr Med Chir; 1994; 16(5):489-90. PubMed ID: 7885961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subsequent manic disorder due to combination vigabatrin-clomipramine].
    Sastre-Garau P; Thomas P; Beaussart M; Goudemand M
    Encephale; 1994; 20(3):363. PubMed ID: 8088239
    [No Abstract]   [Full Text] [Related]  

  • 10. Vigabatrin and complex partial status.
    Arzimanoglou A
    Seizure; 1994 Mar; 3(1):79-80. PubMed ID: 8044458
    [No Abstract]   [Full Text] [Related]  

  • 11. Vigabatrin and psychosis: is there a true correlation?
    Veggiotti P; De Agostini G; Baldi PL; Muzio C; Lanzi G
    Acta Neurol Scand; 1997 Mar; 95(3):189-90. PubMed ID: 9088390
    [No Abstract]   [Full Text] [Related]  

  • 12. Vigabatrin aggravates absences and absence status.
    Cocito L; Primavera A
    Neurology; 1998 Nov; 51(5):1519-20. PubMed ID: 9818915
    [No Abstract]   [Full Text] [Related]  

  • 13. Vigabatrin and multifocal myoclonus in adults with partial seizures.
    Neufeld MY; Vishnevska S
    Clin Neuropharmacol; 1995 Jun; 18(3):280-3. PubMed ID: 8635188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions.
    Wilson EA; Brodie MJ
    BMJ; 1997 Jun; 314(7095):1693. PubMed ID: 9193311
    [No Abstract]   [Full Text] [Related]  

  • 16. Vigabatrin-associated reversible acute psychosis in a child.
    Cánovas Martínez A; Ordovás Baines JP; Beltrán Marqués M; Escrivá Aparisi A; Delgado Cordón F
    Ann Pharmacother; 1995 Nov; 29(11):1115-7. PubMed ID: 8573955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin overdose.
    Davie MB; Cook MJ; Ng C
    Med J Aust; 1996 Oct; 165(7):403. PubMed ID: 8890852
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of association between vigabatrin and impaired cognition.
    Monaco F; Torta R; Cicolin A; Borio R; Varetto A; Bergamasco L; Vighetti S
    J Int Med Res; 1997; 25(5):296-301. PubMed ID: 9364292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The irreversible gamma-aminobutyrate transaminase inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome.
    Stuppaeck CH; Deisenhammer EA; Kurz M; Whitworth AB; Hinterhuber H
    Alcohol Alcohol; 1996 Jan; 31(1):109-11. PubMed ID: 8672169
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.
    Blackwell N; Hayllar J; Kelly G
    BMJ; 1997 Jun; 314(7095):1694. PubMed ID: 9193313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.